Showing results (71-80 of 285) with videos related to

Sort By:
Pageof 29
Cancer|February 3, 2011
A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: a study of the Mayo phase 2 consortium (P2C)Scott Okuno, Howard Bailey, Michelle R Mahoney, et al.
Journal of Internal Medicine|January 18, 2022
The influence of the blood-brain barrier in the treatment of brain tumoursSneha Rathi, Jessica I Griffith, Wenjuan Zhang, et al.
Journal of Neuroinflammation|November 19, 2020
Crosstalk between microglia and patient-derived glioblastoma cells inhibit invasion in a three-dimensional gelatin hydrogel modelJee-Wei Emily Chen, Jan Lumibao, Sarah Leary, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 4, 2022
Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain MetastasesSurabhi Talele, Wenjuan Zhang, Ju-Hee Oh, et al.
Neuro-Oncology|April 16, 2005
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiformeCaterina Giannini, Jann N Sarkaria, Atsushi Saito, et al.
JCI Insight|July 10, 2023
A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastomaWan-Hsin Lin, Ryan W Feathers, Lisa M Cooper, et al.
Journal of Neurosurgery. Case Lessons|January 13, 2025
Recurrent adamantinomatous craniopharyngioma stabilized with tocilizumab and bevacizumab: illustrative caseLauren M Webb, Scott H Okuno, Ryan C Ransom, et al.
Frontiers in Oncology|October 9, 2025
XPO1-inhibitor Selinexor induces MGMT expression by activating PKA-CREB signaling in IDH wildtype glioblastomaJosephine A Mapunda, Yuta Suzuki, Danielle Burgenske, et al.
Neuro-Oncology|June 9, 2021
Experimental design of preclinical experiments: number of PDX lines vs subsampling within PDX linesJeanette E Eckel-Passow, Gaspar J Kitange, Paul A Decker, et al.
Journal of Neurosurgery|September 25, 2007
Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapyEduard B Dinca, Jann N Sarkaria, Mark A Schroeder, et al.
Pageof 29